1/2 sickle cell disease and cardiovascular risk - red cell exchange trial (SCD-carre trial)

Active Cooperative Agreement Awarded Last action

Award ID
UH3HL143192
Recipient
Awarding agency
Obligated
$55,689,051

Award facts

Assistance listing
93.837 Cardiovascular Diseases Research
Completion date 94% complete
Originally
Funding
  • $48,070,070.70 Federal
  • $7,618,980.33 Non-federal
Place of performance
Baltimore, MD 21201, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $117,107 $0
Amendment $117,107 $0
Amendment $117,107 $0
Amendment $1,053,968 $0
Amendment $1,053,968 $0
Amendment $1,053,968 $0
Amendment $1,053,968 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment -$48,467 $0
Amendment -$48,467 $0
Amendment -$680,622 $0
Amendment -$2,887,088 $0
Amendment $3,616,177 $0
Amendment -$2,887,088 $0
Amendment -$2,887,088 $0
Amendment -$680,622 $0
Amendment -$48,467 $0
Amendment $3,616,177 $0
Amendment $3,616,177 $0
Amendment -$680,622 $0
Amendment $208,200 $0
Amendment $208,200 $0
Amendment $208,200 $0
Amendment $208,200 $0
Amendment $2,342,243 $0
Amendment $2,342,243 $0
Amendment $2,342,243 $0
Amendment $2,342,243 $0
Amendment $2,342,243 $0
Amendment $3,349,999 $0
Amendment $3,349,999 $0
Amendment $3,349,999 $0
Amendment $2,667,908 $0
Amendment $2,667,908 $0
Amendment $2,667,908 $0
Amendment $2,667,908 $0
Amendment -$2,667,908 -$2,667,908
Amendment -$2,667,908 $0
Amendment -$2,667,908 $0
Amendment -$2,667,908 $0
Amendment Sickle cell disease and cardiovascular risk- red cell exchange SCD-carre - as patients with sickle cell disease (SCD) live to adulthood, the chronic impact of… -$2,667,908 $0
Amendment $3,348,530 $3,348,530
Amendment $3,348,530 $0
Amendment $3,348,530 $3,348,530
Show 40 more

Latest 50 listed here. See the rest on GovTribe.

Subawards

Subrecipient Amount Awarded
Emory University Sickle Cell Disease and Cardiovascular Risk- Red Cell Exchange SCD-CARRE. $26,977
Duke University As sickle cell disease patients live to adulthood, they develop heart /lung diseases; this clinical trial will evaluate whether a month of red blood cell… $39,000
The Charlotte-Mecklenburg Hospital Authority Sickle Cell Disease and Cardiovascular Risk- Red Cell Exchange SCD-CARRE. $39,000
The Regents Of The University Of California. San Francisco In this clinical trial we will evaluate whether monthly red blood cell transfusions can improve sickle cell patients symptoms and prevent hospitalization and… $39,000
Boston Medical Center Corporation As sickle cell disease patients live to adulthood, they develop heart /lung diseases; this clinical trial will evaluate whether a month of red blood cell… $39,000
Albert Einstein College Of Medicine As sickle cell disease patients live to adulthood, they develop heart /lung diseases. $39,000
University Hospitals Cleveland Medical Center As sickle cell disease patients live to adulthood, they develop heart /lung diseases; this clinical trial will evaluate whether a month of red blood cell… $23,000
The Johns Hopkins University Sickle Cell Disease and Cardiovascular Risk- Red Cell Exchange SCD-CARRE $15,000
University Of Alabama At Birmingham As sickle cell disease patients live to adulthood, they develop heart /lung diseases; this clinical trial will evaluate whether a month of red blood cell… $14,934
University Of Illinois $142,017
East Carolina University As sickle cell disease patients live to adulthood, they develop heart and lung disease; this clinical trial will evaluate whether a month of red blood cell… $15,000
Virginia Commonwealth University As sickle cell disease patients live to adulthood, they develop heart/lung diseases; this clinical trial will evaluate whether a month of red blood cell… $39,000
The Washington University As sickle cell disease patients live to adulthood, they develop heart and lung diseases; this clinical trial will evaluate whether a month of red blood cell… $66,412
Subrecipient not on record Sickle Cell Disease and Cardiovascular Risk- Red Cell Exchange SCD-CARRE. $244,030
Subrecipient not on record $142,000
The Charlotte-Mecklenburg Hospital Authority Sickle Cell Disease and Cardiovascular Risk- Red Cell Exchange SCD-CARRE $56,377
University Hospitals Cleveland Medical Center Sickle Cell Disease and Cardiovascular Risk- Red Cell Exchange SCD-CARRE; As sickle cell disease patients live to adulthood, they develop heart /lung… $205,897
University Of Pittsburgh - Of The Commonwealth System Of Higher Education Sickle Cell Disease and Cardiovascular Risk- Red Cell Exchange SCD-CARRE; As sickle cell disease patients live to adulthood, they develop heart and lung… $971,420
University Of Illinois Sickle Cell Disease and Cardiovascular Risk- Red Cell Exchange SCD-CARRE; As sickle cell disease patients live to adulthood, they develop heart /lung… $179,465
University Of Texas Health Science Center At Houston Sickle Cell Disease and Cardiovascular Risk- Red Cell Exchange SCD-CARRE; As sickle cell disease patients live to adulthood, they develop heart and lung… $278,028
The Regents Of The University Of California. San Francisco Sickle Cell Disease and Cardiovascular Risk- Red Cell Exchange SCD-CARRE; In this clinical trial we will evaluate whether monthly red blood cell transfusions… $39,582
The Johns Hopkins University Sickle Cell Disease and Cardiovascular Risk- Red Cell Exchange SCD-CARRE; As sickle cell disease patients live to adulthood, they develop heart and lung… $255,583
The Regents Of The University Of California. San Francisco Sickle Cell Disease and Cardiovascular Risk- Red Cell Exchange SCD-CARRE $91,446
Icahn School Of Medicine At Mount Sinai Sickle Cell Disease and Cardiovascular Risk- Red Cell Exchange SCD-CARRE; As sickle cell disease patients live to adulthood, they develop heart /lung… $276,566
The Washington University Sickle Cell Disease and Cardiovascular Risk- Red Cell Exchange SCD-CARRE; As sickle cell disease patients live to adulthood, they develop heart and lung… $271,573
Boston Medical Center Corporation Sickle Cell Disease and Cardiovascular Risk- Red Cell Exchange SCD-CARRE; As sickle cell disease patients live to adulthood, they develop heart /lung… $237,548
Howard University Sickle Cell Disease and Cardiovascular Risk- Red Cell Exchange SCD-CARRE; As sickle cell disease patients live to adulthood, they develop heart and lung… $157,137
Duke University Sickle Cell Disease and Cardiovascular Risk- Red Cell Exchange SCD-CARRE; As sickle cell disease patients live to adulthood, they develop heart /lung… $61,289
Emory University $147,280
University Of Alabama At Birmingham $203,489
University Of North Carolina At Chapel Hill Sickle Cell Disease and Cardiovascular Risk- Red Cell Exchange SCD-CARRE; As sickle cell disease patients live to adulthood, they develop heart and lung… $222,412
Virginia Commonwealth University Sickle Cell Disease and Cardiovascular Risk- Red Cell Exchange SCD-CARRE; As sickle cell disease patients live to adulthood, they develop heart/lung diseases;… $92,124
Albert Einstein College Of Medicine Sickle Cell Disease and Cardiovascular Risk- Red Cell Exchange SCD-CARRE; As sickle cell disease patients live to adulthood, they develop heart /lung… $238,192
Subrecipient not on record Sickle Cell Disease and Cardiovascular Risk- Red Cell Exchange SCD-CARRE $418,386
East Carolina University Sickle Cell Disease and Cardiovascular Risk- Red Cell Exchange SCD-CARRE; As sickle cell disease patients live to adulthood, they develop heart and lung… $226,730
Emory University Sickle Cell Disease and Cardiovascular Risk- Red Cell Exchange SCD-CARRE; As sickle cell disease patients live to adulthood, they develop heart /lung… $266,649
University Of Pittsburgh - Of The Commonwealth System Of Higher Education Sickle Cell Disease and Cardiovascular Risk- Red Cell Exchange SCD-CARRE. As sickle cell disease patients live to adulthood, they develop heart and lung… $1,431,521
University Of Illinois Sickle Cell Disease and Cardiovascular Risk- Red Cell Exchange SCD-CARRE. As sickle cell disease patients live to adulthood, they develop heart /lung… $298,510
The Regents Of The University Of California. San Francisco Sickle Cell Disease and Cardiovascular Risk- Red Cell Exchange SCD-CARRE. In this clinical trial we will evaluate whether monthly red blood cell transfusions… $69,267
Duke University Sickle Cell Disease and Cardiovascular Risk- Red Cell Exchange SCD-CARRE. As sickle cell disease patients live to adulthood, they develop heart /lung… $206,395
The Charlotte-Mecklenburg Hospital Authority Sickle Cell Disease and Cardiovascular Risk- Red Cell Exchange SCD-CARRE. As sickle cell disease patients live to adulthood, they develop heart and lung… $194,334
Virginia Commonwealth University Sickle Cell Disease and Cardiovascular Risk- Red Cell Exchange SCD-CARRE. As sickle cell disease patients live to adulthood, they develop heart/lung diseases;… $207,136
Show all 42

Quick answers

Who received award UH3HL143192?

UH3HL143192 was awarded to University Of Maryland, Baltimore by National Heart Lung and Blood Institute (National Institutes of Health) on May 15, 2019.

How much is award UH3HL143192 worth?

$55,689,051 has been obligated on UH3HL143192: $48,070,071 in federal funding and $7,618,980 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award